D-Serine May Ameliorate Hippocampal Synaptic Plasticity Impairment Induced by Patients’ Anti-N-methyl-D-aspartate Receptor Antibodies in Mice
<b>Objective</b>: To establish a mouse model of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis and assess the potential therapeutic benefits of D-serine supplementation in mitigating synaptic plasticity impairments induced by anti-NMDAR antibodies. <b>Methods</b>: Anti-NMDAR antibodies were purified from cerebrospinal fluid (CSF) samples of patients diagnosed with anti-NMDAR encephalitis and verified using a cell-based assay. CSF from patients with non-inflammatory neurological diseases served as the control. These antibodies were then injected intraventricularly into C57BL/6 mice. Forty-eight hours following the injection, mice were administered either D-serine (500 mg/kg) or sterile saline intraperitoneally for three consecutive days. Subsequent analyses included Western blotting, immunofluorescence, electrophysiological studies, and a series of behavioral tests to assess pathological changes caused by anti-NMDAR antibodies. <b>Results</b>: Mice injected with anti-NMDAR antibodies exhibited a significant reduction in hippocampal long-term potentiation compared to controls, which was notably ameliorated by D-serine treatment. Additionally, these mice displayed decreased levels of hippocampal membrane NMDAR1 protein and postsynaptic NMDAR1 density. However, D-serine administration did not significantly alter these conditions. Notably, no significant behavioral differences were observed between mice injected with anti-NMDAR antibodies and controls in open fields, elevated plus maze, novel object recognition, or Morris water maze tests. <b>Conclusions</b>: Our findings indicate that exogenous D-serine can improve hippocampal plasticity impairments caused by anti-NMDAR antibodies but does not reverse the decreased expression of NMDAR. Furthermore, a single intraventricular injection of patients' antibodies was insufficient to induce anti-NMDAR encephalitis-related behaviors in mice.
Authors
- Jianxiong Gui (ORCID: https://orcid.org/0000-0002-8726-2550)
- Hengsheng Chen
- Ziyao Han
- Dishu Huang
- Li Jiang (ORCID: https://orcid.org/0000-0001-8513-5446)
- Xiaoyue Yang (ORCID: https://orcid.org/0000-0002-9331-0512)
- Hanyu Luo (ORCID: https://orcid.org/0000-0003-4018-8821)
- Li Cheng (ORCID: https://orcid.org/0000-0001-8984-0812)
- Jiaxin Yang (ORCID: https://orcid.org/0000-0002-9771-9171)
- Ran Ding (ORCID: https://orcid.org/0000-0002-7453-8968)
- Jiannan Ma
Institutions
- Children's Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-12-18
- DOI
- https://doi.org/10.3390/biomedicines12122882
- Citations
- 4
- Primary Topic
- Amino Acid Enzymes and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.18
Funders
- Natural Science Foundation of Chongqing